Can differences in the type, nature or amount of polysubstance use explain the increased risk of non-fatal overdose among psychologically distressed people who inject drugs?

Drug and Alcohol Dependence

Volumn 154, Issue , 2015, Pages 76-84

  Betts, Kim S ^a   McIlwraith, Fairlie ^a   Dietze, Paul ^b   Whittaker, Elizabeth ^c   Burns, Lucy ^c   Cogger, Shelley ^b   Alati, Rosa ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b BURNET INSTITUTE   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Non fatal overdose; Polysubstance use; Psychological distress; Structural equation modelling

Indexed keywords

COCAINE; DIAMORPHINE; ILLICIT DRUG; METHAMPHETAMINE; OPIATE; OXYCODONE; STREET DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISTRESS SYNDROME; DRUG CONTROL; DRUG OVERDOSE; FEMALE; HEALTH CARE POLICY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION; MIDDLE AGED; NON FATAL OVERDOSE; OPIATE SUBSTITUTION TREATMENT; OUTCOME ASSESSMENT; PRESCRIPTION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SUBSTANCE USE; AUSTRALIA; COMPLICATION; DRUG USE; HIGH RISK BEHAVIOR; MENTAL STRESS; PSYCHOLOGY; STATISTICAL MODEL; SUBSTANCE ABUSE; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AUSTRALIA; DRUG OVERDOSE; DRUG USERS; FEMALE; HUMANS; MALE; MIDDLE AGED; MODELS, STATISTICAL; RISK-TAKING; STREET DRUGS; STRESS, PSYCHOLOGICAL; SUBSTANCE ABUSE, INTRAVENOUS; YOUNG ADULT;

EID: 84938955345     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2015.06.020     Document Type: Article

References (41)

1. Aldao A., Nolen-hoeksema S., Schweizer S. Emotion-regulation strategies across psychopathology: a meta-analytic review. Clin. Psychol. Tev. 2010, 30:217-237.
2. Andrews G., Slade T. Interpreting scores on the Kessler psychological distress scale (K10). Aust. N.Z. J. Public Health 2001, 25:494-497.
3. Baker A., Dawe S. Amphetamine use and co-occurring psychological problems: review of the literature and implications for treatment. Aust. Psychol. 2005, 40:88-95.
4. Bartoli F., Carrà G., Brambilla G., Carretta D., Crocamo C., Neufeind J., Baldacchino A., Humphris G., Clerici M. Association between depression and non-fatal overdoses among drug users: a systematic review and meta-analysis. Drug Alcohol Depend. 2014, 134:12-21.
5. Bennett G.A., Higgins D.S. Accidental overdose among injecting drug users in Dorset, UK. Addiction 1999, 94:1179-1189.
6. Bohnert A.S., Ilgen M.A., Ignacio R.V., McCarthy J.F., Valenstein M., Blow F.C. Risk of death from accidental overdose associated with psychiatric and substance use disorders. Am. J. Psychiatry 2012, 169:64-70.
7. Browne M.W. An overview of analytic rotation in exploratory factor analysis. Multivariate Behav. Res. 2001, 36:111-150.
8. Brugal M.T., Barrio G., Regidor E., Royuela L., Suelves J.M. Factors associated with non-fatal heroin overdose: assessing the effect of frequency and route of heroin administration. Addiction 2002, 97:319-327.
9. Byrne B.M. Structural Equation Modeling With Mplus: Basic Concepts, Applications, And Programming 2012, Routledge Academic, New York.
10. Carter J.L., Strang J., Frissa S., Hayes R.D., Hatch S.L., Hotopf M., Team S.S. Comparisons of polydrug use at national and inner city levels in England: associations with demographic and socioeconomic factors. Ann. Epidemiol. 2013, 23:636-645.
11. Coffin P.O., Galea S., Ahern J., Leon A.C., Vlahov D., Tardiff K. Opiates, cocaine and alcohol combinations in accidental drug overdose deaths in New York City, 1990-98. Addiction 2003, 98:739-747.
12. Conner K.R., Bohnert A.S., McCarthy J.F., Valenstein M., Bossarte R., Ignacio R., Lu N., Ilgen M.A. Mental disorder comorbidity and suicide among 2.96 million men receiving care in the veterans health administration health system. J. Abnorm. Psychol. 2013, 122:256.
13. Connor J.P., Gullo M.J., White A., Kelly A.B. Polysubstance use: diagnostic challenges, patterns of use and health. Curr. Opin. Psychiatry 2014, 27:269-275.
14. Darke S. Opioid overdose and the power of old myths: what we thought we knew, what we do know and why it matters. Drug Alcohol Rev. 2014, 33:109-114.
15. Darke S., Hall W. Heroin overdose: research and evidence-based intervention. J. Urban Health 2003, 80:189-200.
16. Dietze P., Jolley D., Fry C., Bammer G. Transient changes in behaviour lead to heroin overdose: results from a case-crossover study of non-fatal overdose. Addiction 2005, 100:636-642.
17. Elkader A.K., Brands B., Dunn E., Selby P., Sproule B.A. Major depressive disorder and patient satisfaction in relation to methadone pharmacokinetics and pharmacodynamics in stabilized methadone maintenance patients. J. Clin. Psychopharmacol. 2009, 29:77-81.
18. Fairbairn N., Wood E., Stoltz J.-A., Li K., Montaner J., Kerr T. Crystal methamphetamine use associated with non-fatal overdose among a cohort of injection drug users in Vancouver. Public Health 2008, 122:70-78.
19. Fischer B., Brissette S., Brochu S., Bruneau J., El-Guebaly N., Noël L., Rehm J., Tyndall M., Wild C., Mun P. Determinants of overdose incidents among illicit opioid users in 5 Canadian cities. CMAJ 2004, 171:235-239.
20. Hando J., Darke S., O'Brien S., Maher L., Hall W. The development of an early warning system to detect trends in illicit drug use in Australia: the Illicit Drug Reporting System. Addict. Res. Theory 1998, 6:97-113.
21. Hu L.T., Bentler P.M. Fit indices in covariance structure modeling: sensitivity to underparameterized model misspecification. Psychol. Methods 1998, 3:424-453.
22. Jones J.D., Mogali S., Comer S.D. Polydrug abuse: a review of opioid and benzodiazepine combination use. Drug Alcohol Depend. 2012, 125:8-18.
23. Jöreskog K.G. A general approach to confirmatory maximum likelihood factor analysis. Psychometrika 1969, 34:183-202.
24. Kaye S., Darke S. Non-fatal cocaine overdose among injecting and non-injecting cocaine users in Sydney, Australia. Addiction 2004, 99:1315-1322.
25. Kerr T., Fairbairn N., Tyndall M., Marsh D., Li K., Montaner J., Wood E. Predictors of non-fatal overdose among a cohort of polysubstance-using injection drug users. Drug Alcohol Depend. 2007, 87:39-45.
26. Kessler R.C., Andrews G., Colpe L.J., Hiripi E., Mroczek D.K., Normand S.-L., Walters E.E., Zaslavsky A.M. Short screening scales to monitor population prevalences and trends in non-specific psychological distress. Psychol. Med. 2002, 32:959-976.
27. Martin G., Vallance K., MacDonald S., Stockwell T., Ivsins A., Chow C., Michelow W., Duff C. Nonfatal overdose from alcohol and/or drugs among a sample of recreational drug users. J. Subst. Use 2013, 19:239-244.
28. Mégarbane B., Buisine A., Jacobs F., Résière D., Chevillard L., Vicaut E., Baud F.J. Prospective comparative assessment of buprenorphine overdose with heroin and methadone: clinical characteristics and response to antidotal treatment. J. Subst. Abuse Treat. 2010, 38:403-407.
29. Murphy E.L., Devita D., Liu H., Vittinghoff E., Leung P., Ciccarone D.H., Edlin B.R. Risk factors for skin and soft-tissue abscesses among injection drug users: a case-control study. Clin. Infect. Dis. 2001, 33:35-40.
30. Muthén L.K., Muthén B.O. Mplus User's Guide 1998-2010, Muthén & Muthén, Los Angeles.
31. Pabayo R., Alcantara C., Kawachi I., Wood E., Kerr T. The role of depression and social support in non-fatal drug overdose among a cohort of injection drug users in a Canadian setting. Drug Alcohol Depend. 2013, 132:603-609.
32. Quek L.-H., Chan G.C., White A., Connor J.P., Baker P.J., Saunders J.B., Kelly A.B. Concurrent and simultaneous polydrug use: latent class analysis of an Australian nationally representative sample of young adults. Front. Public Health 2013, epub ahead of print.
33. Rhodes T., Briggs D., Kimber J., Jones S., Holloway G. Crack-heroin speedball injection and its implications for vein care: qualitative study. Addiction 2007, 102:1782-1790.
34. Slade T., Grove R., Burgess P. Kessler psychological distress scale: normative data from the 2007 Australian National Survey of Mental Health and Wellbeing. Aust. N.Z. J. Psychiatry 2011, 45:308-316.
35. Stoove M.A., Dietze P.M., Jolley D. Overdose deaths following previous non-fatal heroin overdose: record linkage of ambulance attendance and death registry data. Drug Alcohol Rev. 2009, 28:347-352.
36. Strang J., Mccambridge J., Best D., Beswick T., Bearn J., Rees S., Gossop M. Loss of tolerance and overdose mortality after inpatient opiate detoxification: follow up study. BMJ 2003, 326:959-960.
37. Topp L., Iversen J., Conroy A., Salmon A.M., Maher L. Prevalence and predictors of injecting-related injury and disease among clients of Australia's needle and syringe programs. Aust. N.Z. J. Public Healthb 2008, 32:34-37.
38. Warner-Smith M., Darke S., Day C. Morbidity associated with non-fatal heroin overdose. Addiction 2002, 97:963-967.
39. Warner-Smith M., Darke S., Lynskey M., Hall W. Heroin overdose: causes and consequences. Addiction 2001, 96:1113-1125.
40. Wines J.D., Saitz R., Horton N.J., Lloyd-Travaglini C., Samet J.H. Overdose after detoxification: a prospective study. Drug Alcohol Depend. 2007, 89:161-169.
41. Yokell M.A., Zaller N.D., Green T.C., Rich J.D. Buprenorphine and buprenorphine/naloxone diversion, misuse, and illicit use: an international review. Curr. Drug Abuse Rev. 2011, 4:28.